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Introduction
Radiation therapy (RT) is delivered after radical prostatectomy (RP) either as salvage treatment for
an elevated prostate-specific antigen (PSA) level1-6 or as adjuvant therapy for patients with highrisk pathologic features7-8. Recent prospective data demonstrated a disease-free survival benefit
of adjuvant RT for pathologic T3N0 prostate cancer9-10. Despite literature supporting the delivery
of post-RP RT to the prostatic fossa (PF), no clear target definition guidelines exist for intensity
modulated radiation therapy (IMRT) or image-guided RT (IGRT)11.
Visualization of the PF is limited on standard CT images, with significant interobserver variability
and uncertainty in CTV definition12. Efforts to incorporate complementary imaging modalities
such as MRI for PF target volume definition have generated neither demonstrably more reliable
PF delineation, nor practical contouring guidelines13. Regardless of the imaging modality, direct
visualization and delineation of the PF clinical target volume (CTV) is fraught with uncertainty.
On the other hand, it is possible to distinguish the borders of important nearby pelvic structures,
namely the bladder and the rectum. The reliability of rectal volume definition on helical CT is
supported by analysis of rectal contours defined in a prospective trial, suggesting the feasibility
of rectal dose-volume data collection in a multicenter setting14. Fiorino et al have described a
correlation between PF CTV shift and anterior rectal wall shift for the cranial half of the rectum in
their report of rectal and bladder movement during post-RP RT using weekly CT images15. These
studies support the reliability of CT-defined rectum contours and a limited correlation between PF
CTV and anterior rectal wall, an important tenet in the current study.
The data reported by Fiorino et al. are limited by the infrequency of image collection and the
acquisition of images at a time and place separate from the treatment couch. Though PTV margin
recommendations are not provided by Fiorino et al., they state eloquently that 1), the anteriorposterior movements of rectum and bladder are more important than lateral motion; 2), the rectum
trends anteriorly during an RT course; 3), there is significant correlation between the posterior
CTV border and the anterior rectal wall for the cranial half of the rectum15. Through the use
of CBCT images obtained during post-prostatectomy RT, the interfraction movement of the
dose-limiting pelvic organs may be characterized further. This information may be used for the
careful extrapolation of information regarding motion of the PF target volume. Prior reports have
described the utility of online CBCT imaging during definitive, primary RT for prostate cancer
using equipment similar to that utilized in the current study16.
In our study, we approach the problem of PF target definition through analysis of real-time
CBCT images during post-RP RT, studying the motion of the critical normal tissue structures
that approximate the anterior and posterior anatomical boundaries of the prostatic fossa. Conebeam CT images, obtained during a definitive course of RT, provided information regarding rectal
and bladder movement. For the purpose of estimating appropriate anterior and posterior PF PTV
definition guidelines, the posterior bladder border and the anterior rectum border were considered
as radiographic surrogates for the anterior and posterior PF borders, respectively.

Methods and Materials
The pelvic anatomy of 10 consecutive prostate cancer patients undergoing post-RP RT was studied
retrospectively using CBCT images obtained during the course of treatment. All patients received a
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radiation dose of 68.4 Gy (1.8 Gy/fraction),
delivered with a four-field conformal RT
plan. Planning CT (CTref) scans, with 3 mm
slice thickness, were obtained in the supine
position with contrast dye cystograms and
urethrograms. Patients were instructed to
follow a strict preparatory regimen before
the CTref and during RT in order to ensure
consistent filling and emptying of the bladder
and rectum, respectively. The attending
physician (R.V.) reviewed and approved
CTV, rectum, and bladder CTref volumes
on the helical CT scans for each patient as
a component of standard RT planning and
delivery. At our institution, a standard 1.0 cm
PTV margin is added to the prostatic fossa
CTV, an empirically chosen guideline. The
standard post-RP treatment policy in our
department includes at least every-other-day
CBCT scans for position verification, with
corrective shifts for 5 mm or more. Image
registration using CBCT scans is performed
based upon bony anatomy including femoral
heads, pubic arch, sacrum, ischium and ilium.
CBCT images were obtained 2-5 times weekly
immediately before treatment using the Elekta
Synergy® cone beam system.
CBCT scans (exported with a 1 mm slice thickness) were registered in relation to the planning
CT using the mutual information algorithm on
the CMS FocalSim®. The automatically co-registered images were evaluated for accuracy by
a single observer (T.S.); manual adjustments

SUP
MID

Bladder

INF

Figure 1. Rectum and bladder motion
were recorded at three points along the
distance from seminal vesicle stump to
bladder-urethral junction.

Radiotherapy

Table 1. Characteristics of 10 patients receiving
radiotherapy to PF after radical prostatectomy
Age (years)
Mean
Range

57
44-69

Time from surgery to RT
Median (months)
≤ 9 months (n)
> 9 months (n)

8.2
6
4

Pre-RT PSA (n)
≤ 0.4
> 0.4

6
4

Gleason Score (n)
GS = 6
GS = 7

2
8

Pathologic Tumor Stage (n)
pT2
pT3

5
5

Extracapsular extension (n)
Yes
No
Margin status
Positive
Negative

Figure 2. Representative cone-beam CT scan obtained on the
treatment couch immediately prior to RT.

6
4
4
6

were made when necessary to produce an optimal fusion of images in
relation to the bony pelvic anatomy. The same observer contoured bladder and rectal volumes on all CBCT images of satisfactory quality for
the identification of the rectal and bladder borders. Rectal and bladder
motion was measured from the seminal vesicle stump (SVS) to the bladder-urethral junction (BUJ) (Figure 1). This region was chosen since
it represents the volume at risk for subclinical disease and it includes
the relevant, potentially dose-limiting organs-at-risk (OAR). For each
patient, 3 cross-sectional levels were studied: 1) superior (SUP), one slice
caudal to the SVS; 2) inferior (INF), one slice cranial to the BUJ; and
3) middle (MID), midway between SUP and INF levels. In the crosssectional plane, midsagittal coordinates were measured at the anterior
rectal border and the posterior bladder border and compared to the planning CT volumes and the mean organ position to obtain interfraction
motion. Lateral shifts were not assessable with this technique, and were
not studied due to minimal impact on RT dose delivered to adjacent
organs at risk (bladder and rectum) relative the anterior and posterior
shifts. Inter-organ distance (IOD), the midsagittal difference between
bladder and rectum, was also recorded at each measurement level, as this
quantity may approximate crudely the anteroposterior PF distance. Data
regarding organ volume and movement were collected for each CTref and
CBCT. The mean and the standard deviation of organ border motion
were calculated relative to both CTref and mean organ position.
In order to assess the reproducibility of the rectum and bladder by volume
definition, repeat contours of the rectum and bladder were performed for 2
patients. In separate contouring sessions, the same observer (T.S.) repeated
the organ definition steps using all CBCT scans for both patients. Repeat
measurements of the anterior rectal border and the posterior bladder
border were recorded, and movement relative to CTref was collected. The
difference between the two sets of CBCT organ contours was calculated
to determine the intraobserver variability for bladder and rectum

Figure 3. Sample treatment planning CT scan (CTref) obtained
prior to initiation of RT.

motion measurements. A similar process was followed for rectum and
bladder volume measurements to determine intraobserver variation in
organ volume.
Anterior and posterior PTV margins were calculated by applying a formula (2Σ + 0.7σ) that includes systematic error (Σ) and random error (σ)
of target volume position17, using measured organ border shifts relative to
CTref for each CBCT scan. Interfraction motion of the posterior bladder
border and the anterior rectum border were used in the analysis as substitutes for anterior and posterior PF motion in order to calculate estimated
margin recommendations.

Results
Ten patients undergoing prostatic fossa RT to 68.4 Gy in 38 fractions were
evaluable for this study. Demographic data is displayed in Table 1. A total of
176 CBCT study sets obtained 3-5 times weekly were analyzed. The rectal
and bladder borders were reliably identified in 166 of 176 (93%) of CBCT
images. Figure 2 shows a representative CBCT image. Figure 3 contains a
typical CT image obtained for planning purposes.
Validation of Methods
Repeat contours and measurements for two patients reveal an average
organ movement measurement discrepancy between contour sets of 1.2 ±
1.7 mm for bladder and 1.1 ± 1.0 mm for rectum for each of thirty CBCT
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Table 2. Organ motion and suggested margin guidelines
based on systematic and random error.
Bladder Motion
(mm)

Observed Motion

Table 3. Pearson correlation coefficients among
mean organ motion and mean organ volume.

Relative to Mean

SUP

MID

SUP

MID

INF

CTref
SD
(+ = anterior,
– = posterior)

+0.1
4.4

+0.4
3.7

+1.5
4.0

INF

-2.6
6.0

-1.6
6.3

-2.7
5.8

Relative to Mean
mean organ SD
position for
all scans
(absolute
values)

3.3
2.9

2.9
2.4

3.1
2.9

4.7
4.6

4.8
4.4

4.5
4.6

Systematic Error (Σ)

2.4

2.1

2.1

3.5

3.5

3.1

Random Error (Σ)

3.3

2.8

2.4

4.0

4.5

3.5

Calculated PTV
Margin (2Σ + 0.7Σ)

7.1

6.2

5.9

9.8

10.2

8.6

study sets analyzed. Average variation at SUP, MID, and INF levels for
bladder was 1.0 ± 1.4 mm, 1.0 ± 1.3 mm, 1.5 ± 2.5 mm, and, for rectum, 1.1
± 1.2 mm, 1.1 ± 0.8 mm, and 1.1 ± 1.1 mm, respectively. Mean difference
in bladder volume between the CBCT contours was 2.4 mL (2.6% of mean
organ volume); for rectal volume, 2.5 mL (4.6% of mean organ volume).
Organ Motion
There was a tendency towards posterior movement of the anterior rectal
wall and anterior tendency in the position of the posterior bladder border
during the RT course relative to the CTref. Organ border motion values at
SUP, MID, and INF levels are displayed in Table 2. The calculated posterior margin for PF PTV creation ranged from 8.6 to 10.2 mm, while the
calculated anterior margin for PF PTV ranged from 5.9 to 7.1 mm (Table
2). The mean IOD observed on CTref images was 8.0 ± 5.7 mm, 6.8 ±
5.1 mm, and 5.6 ± 3.5 mm for the SUP,MID and INF levels, respectively.
The average CBCT IOD, based on mean IOD for all patients, was 11.4
± 6.7 mm, 9.4 ± 3.1 mm, and 10.4 ± 4.2 mm for the SUP, MID and INF
levels, respectively.
Organ Volume
The bladder and rectum CBCT volumes measured during the course of
RT were smaller than those obtained on the planning CT. The average
CTref rectum volume was 67.6 ± 50.5 mL , while the average CBCT volume
was 59.5 ± 11.3 mL (8.1 mL difference). For the bladder, the average CTref
volume was 152.3 ± 103.3 mL, while the average CBCT volume was 93.1
± 26.8 mL (59.2 mL difference). When patients with greater than 50%
difference between CTref and average CBCT organ volume were removed
from analysis (2 patients for bladder and 2 patients for rectum), the mean
difference between average CTref and CBCT volumes decreased to 2.9 mL
for rectum and to 40.7 mL for bladder.
Volume and Motion Relationships
Pearson correlation coefficients were calculated to analyze interrelationships among mean organ motion at SUP, MID, and INF levels, as well as
the average of all levels, mean organ volume, and mean IOD. Correlation coefficient values are displayed in Table 3, revealing that the largest
correlation exists between the anterior rectum border position and the
distance between the rectum and bladder, with a correlation coefficient
of 0.71 between the average interorgan distance and the average rectal wall
position. Figure 4 displays the relationship between rectal motion and
rectal volume.
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Bladder
Volume

Rectum
Volume

IOD

Rectum
Motion

-0.15
-0.01
-0.05
-0.07

0.37
0.25
0.29
0.33

-0.68
-0.56
-0.69
-0.71

X
X
X
X

SUP
MID
INF
AVG

-0.14
-0.14
-0.06
-0.12

0.18
0.17
0.11
0.18

0.29
0.18
0.44
0.10

0.42
0.43
0.23
0.45

IOD
SUP
MID
INF
AVG

0.04
-0.07
0.01
0.01

-0.26
-0.21
-0.26
-0.28

X
X
X
X

X
X
X
X

Rectal Motion
(mm)
Rectum Motion
SUP
MID
INF
AVG

Bladder Motion

Discussion
The normal tissue anatomy (bladder and rectum) adjacent to the PF CTV
was readily definable throughout the course of post-RP RT using CBCT.
Relative to the planning CT, a mean posterior shift of the anterior rectal
wall was observed on the CBCT images. The mean rectal volume as contoured on CBCT images during RT was less than the mean CTref volume.
The rectum border shift and rectal volume change noted in this study
may be related to a trend towards reduced rectal volume over time during
prostate RT18-19. Our adjusted analysis of rectum volumes, which showed
smaller mean variations in rectum volume after the removal of two
large, outlying values, suggests that strict adherence to the bowel preparatory regimen may produce a planning CT that is more representative
of the rectum during RT. The recommendation that patients in the
current study present to clinic for RT with a full bladder and an evacuated rectum may have contributed to the small level of rectum volume
variation observed.
In their study of nine patients receiving weekly CT scans during postRP RT, Fiorino et al report a mean anterior shift of the anterior rectal
wall throughout the cranial half of the rectum, but no shift within the
caudal half of the rectum15. In our study, measurements of rectum and

Figure 4. Scatter plot of rectum motion and change in rectum volume.

Radiotherapy

bladder shifts were performed only at levels that included the PF CTV.
The mean posterior shift of the anterior rectum wall relative to CTref
in the current study (1.6-2.7 mm) was small. The standard deviation
of the rectal wall position on CBCT relative to the CTref (5.8-6.3 mm)
demonstrates important interfraction variation in rectal wall position,
noted throughout the region of rectum relevant to the PF CTV, despite
the small average shift observed. Variations in rectal volume appear to
impact the position of the anterior rectum wall (Figure 4). In addition,
the interorgan distance, which may serve as a rough approximation of the
prostatic fossa, correlates more strongly with anterior rectal motion than
with other factors (Table 3), supporting the influence of rectal border
motion on PF CTV delineation.
We recommend the use of a nonuniform margin for PTV definition,
consisting of a 5.9 to 7.1 mm bladder border margin and an 8.6 to 10.2
mm rectal border margin. A published report of significant correlation
between the anterior rectal wall and the prostatic fossa CTV supports, in
part, the rationale of the current study’s approach, though the reported
relationship between rectal and CTV motion occurred only with the
cranial portion of the rectum15. Although the influence of OAR motion
on PF PTV margin definition seems sensible, the extrapolation of target
information from organ motion should be approached with caution.
The use of 3D conformal RT after RP has been shown to reduce toxicity
relative to conventional delivery techniques20. In addition, rectal dosevolume histograms (DVHs) for patients undergoing post-RP RT have
been shown to correlate significantly with risk for late complications21.
Retrospective analyses of patients undergoing salvage post-RP RT suggest a benefit from RT doses 64.8 Gy or higher2-3. As higher RT doses
are delivered to the prostatic fossa, the ability to minimize toxicity of
adjacent tissues rests upon an understanding of motion of both CTV
and OARs during treatment. Intensity-modulated radiation therapy
(IMRT) may allow safe dose-escalation for post-RP RT22, but its application requires detailed target definition guidelines1. CBCT may allow
tighter RT margins when used to conduct IGRT with daily corrections16,
potentially allowing for higher total doses without parallel increases in
OAR dose and treatment-related toxicity.
The current study provides approximate anterior and posterior margins
for PF PTV definition based on calculations using pelvic organ motion
information. Lateral margins were not calculated, as lateral movement is
less significant than anteroposterior motion9 and is unlikely to influence
dose delivered to the adjacent organs at risk (bladder and rectum). Due to
uncertainty in direct definition of the PF CTV, an indirect approach was
utilized based on interfraction rectal and bladder motion. This approach
acknowledges the uncertainty of CTV definition12, 23 while incorporating
the additional anatomic information provided by on-line CBCT imaging
during the RT course. The bladder and the rectum were easily identified
on most CBCT images in the current study. A small number of CBCT
images collected in the current study (7%) were unusable for organ definition due to poor image quality, which may be attributed to technical
errors in image acquisition. The use of bladder and rectum movements
as determinants for PTV margin guidelines may provide a reliable
approach, as rectal contouring has been shown to be reproducible using
helical CT scans14. These data and similar future studies should be pursued to better define target-definition guidelines for post-RP conformal
RT. Avenues for future applications of CBCT images in post-RP RT may
include daily online localization with manual soft-tissue registration and
subsequent corrective shifts in patient position, as well as off-line adaptive RT based upon a set of CBCT scans obtained during the first week
of RT in a fashion similar to that described previously by Yan et al24. The

current work may be used in future attempts to develop off-line adaptive
strategies for RT that rely upon conformal avoidance of the rectum and
bladder to target the PF CTV for post-prostatectomy patients.
In conclusion, normal tissue anatomy (bladder and rectum) used to define
the anterior and the posterior border of the prostatic fossa was readily definable by CBCT imaging throughout the course of post-RP RT. In
the absence of direct, target-based treatment guidelines available, CBCT
definition of bladder and rectum volumes may be used to pursue anterior
and posterior PTV margin recommendations.
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